FDA cleared the PolySense from Itamar Medical , Ltd. on Oct 30, 2026 under K260648, a traditional 510(k). The device falls under product code GWL, Amplifier, Physiological Signal, regulated at 21 CFR 882.1835 as a Class 2 device. The review panel was Neurology.
FDA logged the submission as received on Feb 27, 2026. The decision came 245 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
Itamar Medical , Ltd. has one other decision in the tracker over the last 12 months: K254042 (WatchPAT SW).